PDCD1LG2 and cancer: We recently found that the PI3K/PTEN signaling pathway is driving CD8α+DCs expressing PD-L1 and PD-L2 and impairing efficient CD8 T-cell responses in two different cancer models in a myeloid-PTEN (PTENΔmye) specific mouse model (13).